Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts.

Walker N, Badri L, Wettlaufer S, Flint A, Sajjan U, Krebsbach PH, Keshamouni VG, Peters-Golden M, Lama VN.

Am J Pathol. 2011 Jun;178(6):2461-9. doi: 10.1016/j.ajpath.2011.01.058.

2.

Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allografts.

Walker NM, Badri LN, Wadhwa A, Wettlaufer S, Peters-Golden M, Lama VN.

Am J Respir Crit Care Med. 2012 Jan 1;185(1):77-84. doi: 10.1164/rccm.201105-0834OC.

3.

Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.

Badri L, Murray S, Liu LX, Walker NM, Flint A, Wadhwa A, Chan KM, Toews GB, Pinsky DJ, Martinez FJ, Lama VN.

Am J Respir Crit Care Med. 2011 Apr 15;183(8):1062-70. doi: 10.1164/rccm.201005-0742OC. Epub 2010 Dec 17.

4.

Endothelin-1 governs proliferation and migration of bronchoalveolar lavage-derived lung mesenchymal stem cells in bronchiolitis obliterans syndrome.

Salama M, Andrukhova O, Jaksch P, Taghavi S, Kelpetko W, Dekan G, Aharinejad S.

Transplantation. 2011 Jul 27;92(2):155-62. doi: 10.1097/TP.0b013e318222c9ea.

PMID:
21701423
5.

Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.

LaPar DJ, Burdick MD, Emaminia A, Harris DA, Strieter BA, Liu L, Robbins M, Kron IL, Strieter RM, Lau CL.

Ann Thorac Surg. 2011 Aug;92(2):470-7; discussion 477. doi: 10.1016/j.athoracsur.2011.04.065.

6.

Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation.

Kelly FL, Kennedy VE, Jain R, Sindhwani NS, Finlen Copeland CA, Snyder LD, Eu JP, Meltzer EB, Brockway BL, Pavlisko E, Stripp BR, Palmer SM.

Am J Transplant. 2012 Nov;12(11):3076-84. doi: 10.1111/j.1600-6143.2012.04201.x. Epub 2012 Aug 6.

7.

Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.

Liu M, Zeng X, Wang J, Fu Z, Wang J, Liu M, Ren D, Yu B, Zheng L, Hu X, Shi W, Xu J.

Stem Cell Res Ther. 2016 Apr 23;7(1):63. doi: 10.1186/s13287-016-0319-y.

8.

Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation.

Bergmann M, Tiroke A, Schäfer H, Barth J, Haverich A.

Scand Cardiovasc J. 1998;32(2):97-103.

PMID:
9636965
9.

Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation.

Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA.

Arthritis Rheum. 2010 Dec;62(12):3695-705. doi: 10.1002/art.27710.

10.

Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.

Zheng L, Walters EH, Ward C, Wang N, Orsida B, Whitford H, Williams TJ, Kotsimbos T, Snell GI.

Thorax. 2000 Jan;55(1):53-9.

11.

Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.

Lama VN, Smith L, Badri L, Flint A, Andrei AC, Murray S, Wang Z, Liao H, Toews GB, Krebsbach PH, Peters-Golden M, Pinsky DJ, Martinez FJ, Thannickal VJ.

J Clin Invest. 2007 Apr;117(4):989-96. Epub 2007 Mar 8.

12.

The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.

Krustrup D, Iversen M, Martinussen T, Schultz HH, Andersen CB.

Clin Transplant. 2015 Mar;29(3):179-84. doi: 10.1111/ctr.12502. Epub 2015 Mar 9.

PMID:
25533723
13.

Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.

Mimura T, Walker N, Aoki Y, Manning CM, Murdock BJ, Myers JL, Lagstein A, Osterholzer JJ, Lama VN.

Am J Pathol. 2015 Jun;185(6):1564-74. doi: 10.1016/j.ajpath.2015.03.002. Epub 2015 Apr 4.

14.

Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN.

J Immunol. 2008 Sep 15;181(6):4389-96.

15.

Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.

Langenbach SY, Zheng L, McWilliams T, Levvey B, Orsida B, Bailey M, Williams TJ, Snell GI.

J Heart Lung Transplant. 2005 Oct;24(10):1550-6.

PMID:
16210129
16.

Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung.

Sinclair KA, Yerkovich ST, Hopkins PM, Chambers DC.

Stem Cell Res Ther. 2016 Jul 12;7(1):91. doi: 10.1186/s13287-016-0354-8.

17.

Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model.

Zhao Y, Gillen JR, Harris DA, Kron IL, Murphy MP, Lau CL.

J Thorac Cardiovasc Surg. 2014 May;147(5):1668-1677.e5. doi: 10.1016/j.jtcvs.2013.09.041. Epub 2013 Nov 4.

18.

Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.

Mamessier E, Milhe F, Badier M, Thomas P, Magnan A, Reynaud-Gaubert M.

J Heart Lung Transplant. 2006 May;25(5):523-32. Epub 2006 Apr 11.

PMID:
16678030
19.

Identity and ranking of colonic mesenchymal stromal cells.

Signore M, Cerio AM, Boe A, Pagliuca A, Zaottini V, Schiavoni I, Fedele G, Petti S, Navarra S, Ausiello CM, Pelosi E, Fatica A, Sorrentino A, Valtieri M.

J Cell Physiol. 2012 Sep;227(9):3291-300. doi: 10.1002/jcp.24027.

PMID:
22170005
20.

Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition.

Hodge S, Holmes M, Banerjee B, Musk M, Kicic A, Waterer G, Reynolds PN, Hodge G, Chambers DC.

Am J Transplant. 2009 Apr;9(4):727-33. doi: 10.1111/j.1600-6143.2009.02558.x.

Supplemental Content

Support Center